Population
Patients with hypertrophic cardiomyopathy
Design
Guideline
Key result
Hypertrophic cardiomyopathy can feature systolic dysfunction (EF 50%) associated with left ventricular remodeling, cavity enlargement, wall thinning, and diffuse myocardial scarring.
Authors
Loading...
Recognize end-stage HCM progression in practice; reinforces guideline inclusion of adverse remodeling phenotypes.
This document serves as the 2011 ACCF/AHA executive summary for the clinical diagnosis and management of hypertrophic cardiomyopathy.
Gersh et al. (2011) studied this question. Hypertrophic cardiomyopathy can feature systolic dysfunction (EF 50%) associated with left ventricular remodeling, cavity enlargement, wall thinning, and diffuse myocardial scarring.